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The objective of this project is to generate a library of monoclonal antibodies (MAbs) directed
against surface molecules of tumor and transformed cells grown as multicell spheroids (MCS).
These MCS are highly organized, 3-dimensional multicellular structures which exhibit many
characteristics of in vivo organized tissues which are not found in conventional monolayer or
suspension culture. In brief, MCS combine the relevance of organized tissues with in vitro
methodology making the MCS a good model system to study the interactions of mammalian cells,
and thereby provide a functional assay for surface adhesion molecules.
This project also involves investigations of cell-cell interactions in a gravity-based environment. It
will provide an important base of scientific information for future comparative studies on the
effects of hypergravity and simulated microgravity environments on cell-cell interactions. This
project also has the potential to yield important materials (e.g., cellular products) which may be
useful for the diagnosis and/or treatment of certain human diseases. Moreover, this project
supports the training of one undergraduate and one graduate students; thus, it will also assist in
developing a pool of future scientists with research experience in gravitational biology research.
Research Progress Summary
The aims for this reporting period were: (1) to continue expansion, cloning, and characterization of
MAbs; (2) to continue functional assays with MAbs; and (3) to initiate immunoprecipitation and
Western blot analysis of surface molecules using MAbs from our library.
Two new MAbs directed against surface molecules of human neuroblastoma cells were isolated
and cloned. The MAbs (GMJ-1, and GMJ-2) are of the IgG1 Kappa isotype. Various other
hybridomas from the same fusion with different binding patterns are currently being cloned and
characterized. MAbs directed against surface molecules of human glioblastoma cells were also
generated and isolated. Binding pattems of selected MAbs are being characterized using
immunofluorescence microscopy.
The panel of MAbs directed against surface molecules of WI38SV40 cells were further
characterized on two chinese hamster ovary (CHO) cell lines since in the last progress report we
noted that two of the MAbs (WSJ-3,4) exhibited slightly higher binding on CHO cells. This
observation is of interest since these MAbs do not bind to any other rodent cell lines tested thus far.
In addition, recent results showed that five MAbs directed against WI38SV40 surface antigens
(MTS 1.2, WSJ-4,5,7,9) also exhibited slightly higher binding on the CHO Pro-5 cell line, and
only one MAb (WSJ-5) exhibited slightly higher binding on CHO Spinner (aggregation-deficient)
cells. Three MAbs (WSJ-5,7,9)exhibited slightly higher binding to B 14150 (hamster) mutant
ConA R-2DF-F1 cell line.
A study comparing MAb binding on normal WI38 fibroblasts of different passage (age) levels was
initiated the reporting period. Preliminary results showed that early-passage cells exibited a lower
binding intensity than did either mid-passage or late passage WI38 cells. Further comparative
studies utlizing a wider range of passage levels will be conducted during the next six-month
period.
The BSG-1 MAb reported previously was tested in functional assays on the 2DF*F1 cells
(compaction-deficient mutant of B 14150 cells). Preliminary results showed that after 24 hr of
incubation of 2DF*F 1 cells in the presence of the MAb, an increase in cell aggregation, as
comparedto thecontrol,wasobserved.
PreliminaryWesternblot analysisof surfacemolecules of WI38SV40 cells was also initiated
during the reporting period. Commercial surface proteins and antibodies were used to determine
optimal experimental conditions. In addition, a radiolabeled centrifugal assay to measures cell-cell
adhesion is currently being developed. This assay will be utilized in functional studies utilizing
MAbs to quantitate their effects on cell-cell interactions of WI38SV40 and other cells.
A rotary cell culture sytem was recently purchased to study the effects of MAbs on cell-cell
interaction in a simulated microgravity environment. Currently, optimal conditions and reagent
concentrations of reagents are being determined.
In addition, I spent 10 weeks during the summer conducting research in the Life Sciences Division
at the NASA-AMES Research Center in Moffet Field, California. This research was conducted in
the laboratory of Dr. Rosalyn Grymes and focused on the effects of mechanical forces on the
orientation response of cultured mammalian cells. A summary of this work is included in the
Appendix.
Future Plans
The specific alms for the next six-month period are: (1) to continue the cloning, expansion, and
characterization of MAbs; (2) to continue immunoprecipitation and Western blot analysis of surface
molecules with selected MAbs; (3) to continue experiment preparation for utilizing the rotary cell
culture system for testing for testing the effects of MAbs on cell-cell interations in a simulated
microgravity environment; and (4) to continue optimization of the radiolabeled centrifugal assay to
quantitate cell-cell adhesion.
In addition, I plan to return to NASA-AMES in summer of 1995 to continue my studies on the
effects of mechanical force on the behavior of mammalian cells. In particular, I would like to study
the effect of mechanical force on cytoskeletal elements such as actin filaments, microtubules and
intermediate f'tlaments, and the role of integrins and cadherins in mammalian cell alignment in




ANTIBODY CELL LINE AVG. MEAN* AVG, NET FLUORESCENI_E*
MTS 1.2 W138sv40 505.8 308.6
IMR90sv40 587.6 425.2
IMR90 P7 361.6 136.2
IMR90 P10 388.0 160.8
BSG-1 W138sv40 493.5 296.2
IMR90sv40 563.9 401.5
IMR90 P7 360.2 134.7
IMR90 P10 382.9 155.7
WSJ-2 W138sv40 489.2 292.0
I M R90sv40 561.3 381.4
IMR90 P7 347.4 121.8






































AVG.MEAN* AVG. NET FLUORESCENCE*
WSJ-7 W138sv40 469.2 271.9
IMR90sv40 563.0 400.6
IMR90 P7 338.2 11 8.0
IMR90 P10 356.0 128.8
WSJ-8 W138sv40 497.4 300.0
IMR90sv40 550.0 387.6
IMR90 P7 339.0 11 3.6
IMR90 P10 360.0 132.8
WSJ-9 W138sv40 485.5 288.2
IMR90sv40 540.3 377.9
IMR90 P7 330.0 104.5
IMR90 P10 340.8 113.7
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W'[tt7B: FLOW CYTOMETRY SUMMARY CONT.
ANTIBODY CELL LINE MEAN* NET FLUORESCENCE*
WSJ-7 W138sv40 571.3 383.2
CHO Spinner 249.8 37.8
CHO Pro-5 329.7 141.6
2DF*F1 330.8 132.7
WSJ-8 W138sv40 586.9 398.8
CHO Spinner 365.6 153.6
CHO Pro-5 269.6 81.5
2DF*F1 253.8 55.7
WSJ-9 W138sv40 635.0 446.9
CHO Spinner 267.6 55.6
CHO Pro-5 379.2 191.1
2DF*F1 371.6 173.5
* All numbers are linear
Samples were originally run in duplicate, but the tubes were combined when the
samples were read on the Facs machine. Also, WSJ-6 was negative on the WI38sv40
cells so these samples were not considered.
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A) Control well contianing 2DF*F1 cells in Iscoves media with 10% Fetal clone at 5
clays (10x). B) Well containing 2DF*F1 cells with BSG-1, 3 day supernatant at 5 days
(lOx).
C
C] Well containing 2DF*F1 cells with BSG-1 concentrated supernatant 1:20 at 5 days
(2Ox).
A B
A) Control well containing 2DF*F1 cells in Iscoves media with 10% Fetal Clone at 24
hrs. (10x). B) Well containing 2DF*F1 cells with BSG-1, 3 day supernatant at 24 hours
(10x).
C D
C) Well containing 2DF*F1 cells with BSG-1 exhausted supernatanl at 24 hotlrs (10x).
D) Well containing 2DF*F1 cells with BSG-1 concentrated superna',sr, t (from 2. !iters
to 50 mls) diluted in serum-free isoves 1:20 at 2,1 hrs (I0×).


